Today: 9 June 2026
Browse Category

NYSE:SAN 10 October 2025 - 21 May 2026

IBEX 35 week ahead: Oil shock risk, Santander jitters and fresh data in focus on Spain’s BME

IBEX 35 week ahead: Oil shock risk, Santander jitters and fresh data in focus on Spain’s BME

Spanish stocks reopen Monday after U.S. and Israeli strikes on Iran raised supply fears and pushed Brent oil toward $100. The IBEX 35 last closed down 0.73% at 18,360.80, with banks under pressure after Santander fell 2.8% on UK credit worries. Acciona Energia proposed a 93% dividend cut and flagged 2 billion euros in asset sales. Amadeus beat earnings forecasts and approved a 500 million euro buyback.
1 March 2026
··
Santander rolls out 2% deposit mortgage for UK first-time buyers — here’s the fine print

Santander rolls out 2% deposit mortgage for UK first-time buyers — here’s the fine print

Santander UK launched a five-year fixed mortgage allowing first-time buyers to borrow up to 98% of a home’s value, with a minimum £10,000 deposit and borrowing capped at £500,000. Brokers and consumer groups warned of higher rates and negative-equity risks for buyers with small deposits. The deal is open only to first-time buyers. Santander said the offer aims to address deposit barriers in the housing market.
3 February 2026
Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Federal Reserve officials signaled no urgency for further rate cuts, with New York Fed President John Williams and Cleveland Fed President Beth Hammack both emphasizing a steady approach. Key U.S. economic data delayed by a government shutdown will be released during a shortened Christmas trading week, increasing uncertainty for bank stocks. Markets will close Dec. 25; volatility may rise due to thin liquidity.
21 December 2025
··············
UK Economy News Today (3 December 2025): BoE Loosens Bank Rules as Services PMI, Tourism and Brexit Study Shape Outlook

UK Economy News Today (3 December 2025): BoE Loosens Bank Rules as Services PMI, Tourism and Brexit Study Shape Outlook

The Bank of England cut its Tier 1 capital requirement for major lenders from 14% to 13%, its first reduction since the financial crisis, urging banks to boost lending. All seven top UK banks passed the latest stress test. The OECD raised its 2026 UK GDP growth forecast to 1.2%, but warned of ongoing fiscal pressures. Business closures hit their lowest since 2016, while tourism surged ahead of Christmas.
3 December 2025
······
Santander, Barclays, NatWest and Lloyds Customers Urged to Switch as Bank Deals Pay Up to £400 – Latest Deadlines on 28 November 2025

Santander, Barclays, NatWest and Lloyds Customers Urged to Switch as Bank Deals Pay Up to £400 – Latest Deadlines on 28 November 2025

Santander increased its current account switch offer on 28 November, adding a £25 Amazon gift card to its existing £200 cash bonus for eligible new customers. Barclays closed its £400 Premier switch deal yesterday, but today is the final deadline for its ISA transfer bonus of up to £500. MoneySavingExpert updated its best current account rankings this morning.
28 November 2025
····
XRP Price Primed for Breakout? Whales and ETF Hype Fuel Rally as Ripple Aims to Become a Bank

XRP Price Surges 8% to $2.60 After 40% Flash Crash – Will ETF Hype Push It Beyond $3?

XRP traded at $2.55–$2.65 on Oct. 14, rebounding sharply after a 42% plunge to $1.64 on Oct. 10 triggered by U.S.–China tariff news and heavy liquidations. Whale selling moved 320 million XRP to exchanges during the crash. The SEC settled with Ripple in August, clearing XRP’s regulatory status. Multiple spot XRP ETF filings await likely SEC approval by late October.
14 October 2025
·····
XRP Price Predictions 2026: Will Ripple Soar to $8 or Crash Below $1? Latest Price, ETF and Legal Updates

XRP Price Predictions 2026: Will Ripple Soar to $8 or Crash Below $1? Latest Price, ETF and Legal Updates

XRP traded near $2.38 on Oct 12, 2025, after plunging 42% intraday on Oct 10 before rebounding. Whale wallets moved $1.25 billion off exchanges in a month, fueling analyst warnings of heavy selling pressure. Ripple settled with the SEC in August, clearing the way for U.S. relisting and six spot ETF filings. Over 300 banks now use RippleNet, with new partnerships and upgrades expanding XRP’s payment utility.
12 October 2025
·······
XRP vs Bitcoin – The Ultimate 2025 Price Showdown (New Highs, Legal Wins & Bold Forecasts)

XRP vs Bitcoin – The Ultimate 2025 Price Showdown (New Highs, Legal Wins & Bold Forecasts)

Bitcoin hit a record high above $125,000 in October 2025, with market cap topping $2 trillion after U.S. approval of spot ETFs fueled institutional inflows. XRP surged near $3.00 following a court ruling it is not a security and the end of the SEC’s case against Ripple. Major U.S. exchanges relisted XRP, and banks piloted its use for cross-border payments. A weaker dollar and U.S. government shutdown drove further demand for both assets.
10 October 2025
····

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Go toTop